3 Growth Companies With High Insider Ownership Expect Earnings Growth Up To 63%

Over the last 7 days, the United States market has risen by 1.5%, contributing to a remarkable 26% climb over the past year, with earnings forecasted to grow by 17% annually. In this flourishing environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and potential for substantial earnings expansion.

Top 10 Growth Companies With High Insider Ownership In The United States

Name Insider Ownership Earnings Growth Uxin (UXIN) 35.7% 74.1% Upstart Holdings (UPST) 12.8% 58.5% Strive Asset Management (ASST) 16% 72.2% Ramaco Resources (METC) 10.7% 103.7% Precigen (PGEN) 11.9% 68.4% Laird Superfood (LSF) 16.1% 93.8% Karman Holdings (KRMN) 17% 53.2% Clene (CLNN) 10.9% 61.7% Astera Labs (ALAB) 10.8% 31.5% AppLovin (APP) 27.4% 21.4%

Click here to see the full list of 185 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

Immix Biopharma

Simply Wall St Growth Rating: ★★★★★☆

Overview: Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing chimeric antigen receptor cell therapy for light chain amyloidosis and immune-mediated diseases, with a market cap of $525.88 million.

Operations: Revenue Segments (in millions of $): null

Insider Ownership: 12.8%

Earnings Growth Forecast: 63.4% p.a.

Immix Biopharma is a growth-focused company with high insider ownership, currently navigating financial challenges with a reported net loss of US$10.09 million for Q1 2026. Despite this, its revenue is forecasted to grow significantly faster than the US market at 56.6% annually, driven by promising developments like NXC-201 for AL Amyloidosis. The company anticipates profitability within three years, although it has experienced substantial shareholder dilution and share price volatility recently.

Get an in-depth perspective on Immix Biopharma's performance by reading our analyst estimates report here. Our valuation report here indicates Immix Biopharma may be overvalued.IMMX Earnings and Revenue Growth as at May 2026

Rumble

Simply Wall St Growth Rating: ★★★★★☆

Overview: Rumble Inc. operates a video sharing and cloud services platform across the United States, Canada, and internationally, with a market cap of approximately $2.77 billion.

Operations: The company's revenue is generated from its Internet Software & Services segment, amounting to $100.62 million.

Insider Ownership: 35.9%

Earnings Growth Forecast: 56.8% p.a.

Rumble Inc. exhibits high insider ownership and is positioned for substantial growth, with revenue forecasted to expand at 42.5% annually, outpacing the US market. Recent initiatives like the OpenClaw Starter package on Rumble Cloud highlight its innovative approach in AI infrastructure. Despite a history of volatility and financial losses, Rumble's strategic leadership changes and product expansions aim to drive profitability within three years, reflecting its commitment to long-term value creation amidst market challenges.

Story Continues

Click to explore a detailed breakdown of our findings in Rumble's earnings growth report. Upon reviewing our latest valuation report, Rumble's share price might be too optimistic.RUM Earnings and Revenue Growth as at May 2026

Once Upon A Farm PBC

Simply Wall St Growth Rating: ★★★★★☆

Overview: Once Upon A Farm, PBC is a company that produces and sells organic baby food pouches, meals, and snacks for children with a market cap of $643.58 million.

Operations: The company's revenue is derived from the production and sale of organic baby food pouches, meals, and snacks for children.

Insider Ownership: 13.7%

Earnings Growth Forecast: 55.8% p.a.

Once Upon A Farm PBC demonstrates significant insider ownership and is poised for growth, with revenue projected to increase at 20.6% annually, surpassing US market averages. The company recently reported a substantial sales increase to US$72.72 million in Q1 2026 from US$50.6 million the previous year, while reducing net losses. Strategic product expansions and the formation of a Public Benefit Corporation Advisory Board underscore its commitment to sustainable growth and impactful business practices amidst evolving market demands.

Unlock comprehensive insights into our analysis of Once Upon A Farm PBC stock in this growth report. Our expertly prepared valuation report Once Upon A Farm PBC implies its share price may be too high.OFRM Ownership Breakdown as at May 2026

Make It Happen

Unlock our comprehensive list of 185 Fast Growing US Companies With High Insider Ownership by clicking here. Ready For A Different Approach? These 23 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include IMMXRUM and OFRM.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments